Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade Inc (NQ: ACCD )

11.77 -0.11 (-0.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 371,552
Open 11.54
Bid (Size) 11.64 (2)
Ask (Size) 18.84 (2)
Prev. Close 11.88
Today's Range 11.36 - 11.83
52wk Range 4.610 - 43.88
Shares Outstanding 71,209,436
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here
Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga

Performance

YTD
-56.70%
-56.70%
1 Month
-0.84%
-0.84%
3 Month
+39.13%
+39.13%
6 Month
-28.14%
-28.14%
1 Year
-72.67%
-72.67%

More News

Read More
Analyst Ratings for Accolade
Via Benzinga
Here's Why Accolade Shares Are Trading Higher Today
Via Benzinga
Accolade Shares Slip After Q1 Results, Guides Q2 Revenue Below Consensus
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
Via Benzinga
Where Accolade Stands With Analysts
Via Benzinga
Priority Health announces launch of new health navigation solution, PriorityGPS™
From Priority Health
Via Business Wire
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
Via Benzinga
U.S Stocks Turn Lower; Dow Tumbles Over 100 Points
Via Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
Via Benzinga
10 Analysts Have This to Say About Accolade
Via Benzinga
Accolade Moves Higher But Growth Is Slowing
Via MarketBeat
U.S. Stock Futures Edge Lower Ahead Of Manufacturing Data
Via Benzinga
Micron, Akebia Therapeutics And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Earnings Scheduled For June 30, 2022
Via Benzinga
Earnings Preview For Accolade
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
NASDAQ: ACCD Investor Alert: Investigation over Potential Wrongdoing at Accolade, Inc.
Via SBWire
NASDAQ:ACCD Shareholder Notice: Investigation over Potential Securities Laws Violations by Accolade, Inc.
Via SBWire
Ongoing Investigation Notice: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Earnings
Exposures Financial
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Earnings
Exposures Financial
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.